Neurodevelopmental Disorders | CHOP Research Institute

Neurodevelopmental Disorders

Published on
Oct 14, 2022
Read the latest findings and new grants from Children’s Hospital of Philadelphia researchers.
Dr. Stephenson is an attending pediatric neurologist and medical director of Operations and Outreach for the Division of Neurology at CHOP. She has special interest in neurobehavioral and neurodevelopmental disorders including ADHD, autism, Tourette syndrome, learning disabilities, and developmental delay.
stephensond [at]
Dr. Saby uses electrophysiological techniques to characterize aspects of brain function and development in children with neurodevelopmental disabilities.
sabyj [at]

The Izumi Lab aims to elucidate the molecular mechanism of pediatric neurodevelopmental genetic disorders toward the goals of identifying key pathways/molecules that can be used as therapeutic targets in these diagnoses.

The Department of Child and Adolescent Psychiatry and Behavioral Sciences' research aims to improve the immediate health and developmental trajectory of children.

The Neuromotor Performance Lab (NMPL) is a destination for innovative study and evaluation of motor performance in infants, children, and adolescents.

Research by Dr. Yerys focuses on the development of cognitive and neural mechanisms that support adaptive behavior in children with neurodevelopmental disorders.

yerysb [at]

Dr. Glessner’s current research focuses on childhood neuropsychiatric and neurodevelopmental disorders along with the genetic architecture associated with them, including single nucleotide polymorphisms, single nucleotide variations, and copy number variations ascertained by genomic technologies.

glessner [at]

Dr. Ortiz-Gonzalez is a physician-scientist specializing in pediatric neurogenetics. Her clinical work focuses on finding a unifying genetic diagnosis for children with rare neurodevelopmental disorders. Her research is informed by her patients and focuses on understanding how genetic changes, in particular those affecting mitochondrial function, cause disease so we can develop better treatments for these children in the future.

Published on
Dec 9, 2015
Half of infants born with severe congenital heart disease go on to develop neurodevelopmental disorders, which may include cognitive, motor, social, and language impairments.